$CLS

Chawla Mandeep sold $324K of CLS

Chawla Mandeep (Chief Financial Officer) sold 883 shares of CELESTICA INC (CLS) at an average of $366.52 ($360.00–$374.03, $0.32M total) across 9 trades on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chawla Mandeep
Published Aug 3, 2026, 10:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
high confidence
Mentioned
$CLS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

Insider selling under a pre-arranged plan is typically treated as low-signal; traders may monitor for patterns but usually do not reprice the stock on a single sale.

02

Market read

A routine 10b5-1 insider sale was filed, with no accompanying company-specific news.

03

What to watch

The sale size is modest relative to a large-cap issuer, and the 10b5-1 structure reduces the signal of timing or information advantage.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-03 after-hours; transaction dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica Inc.

Company-level read

Ticker impact

$CLSNeutralHigh confidence
Context

Celestica CFO Chawla Mandeep sold about $323.6K of CLS shares via an open-market sale under a 10b5-1 plan on 2026-07-31.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new guidance, contract, or regulatory development.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can be interpreted as reduced confidence, though this specific disclosure lacks corroborating new fundamentals.

Key entities

  • Celestica Inc

    Subject of the Form 4 insider transaction disclosure (CLS).

  • Chawla Mandeep

    Chief Financial Officer who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.